DNA-
binding protein 43 kDa), tau, and FUS (fused in sarcoma) proteins, which possess antiviral
KLIMENTOVA, E.A.,
GILYAZOVA, I.R.,
BERMISHEVA, M.A.,
BLINNIKOVA, A. M.,
SAFIULLIN, R.I.,
IZMAILOV, A.A.,
YANG, B.,
PAVLOV ., V.N,
KHUSNUTDINOVA, E.K. (2020) binding site with the risk of developing clear cell renal cell carcinoma (ccRCC). As a result
Sun, Pengfei,
Wang, Jiaqi,
Ilyasova, Tatiana,
Shumadalova, Alina,
Agaverdiev, Murad,
Wang, Chunlei (2023) binding to complementary target sequences within messenger
RNA (m
RNA) molecules, consequently exerting a
МИКРО-РНК В ДИАГНОСТИКЕ И ЛЕЧЕНИИ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦАAPPLICATION OF
MICRO-RNA IN THE DIAGNOSIS AND TREATMENT OF CORONARY HEART DISEASE
conducted. Mi
RNA targets
sites are a promising new area of research. In this study, we analyzed
Beylerli, Ozal,
Beilerli, Aferin,
Ilyasova, Tatiana,
Shumadalova, Alina,
Shi, Huaizhang,
Sufianov, Albert (2024) functions is acting as a
microRNA sponge, modulating protein transcription levels, and forming interactions
Gilyazova, I.,
Ivanova, E.,
Gilyazova, G.,
Sultanov, I.,
Izmailov, A.,
Safullin, R.,
Pavlov, V.,
Khusnutdinova, E. (2021) , such as that observed in malignant tumors. We hypothesized that
microRNA genes methylation may be associated with renal